List of Tolak drug patents

Tolak is owned by Hill Dermaceuticals.

Tolak contains Fluorouracil.

Tolak has a total of 1 drug patent out of which 0 drug patents have expired.

Tolak was authorised for market use on 18 September, 2015.

Tolak is available in cream;topical dosage forms.

The generics of Tolak are possible to be released after 18 July, 2023.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7169401 HILL DERMACEUTICALS Topical skin care composition containing refined peanut oil
Jul, 2023

(3 months from now)

Drugs and Companies using FLUOROURACIL ingredient

Market Authorisation Date: 18 September, 2015

Treatment: NA


More Information on Dosage

TOLAK family patents


United States




European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in